Kotaro Sugimoto

Dr. Kotaro Sugimoto

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2008 in Molecular Biology of the Cell
Verified
Journal Article
Closed access
HFHiroki Fujita
Hiroki Fujita
Kotaro SugimotoKotaro Sugimoto
Kotaro Sugimoto
SIShuichiro Inatomi
Shuichiro Inatomi
TMToshihiro Maeda
Toshihiro Maeda
MOMakoto Osanai
Makoto Osanai
HCHideki Chiba
Hideki Chiba
Ca2+ is absorbed across intestinal epithelial monolayers via transcellular and paracellular pathways, and an active form of vitamin D3, 1α,25-dihydroxyvitamin D3 [1α,25(OH)2D3], is known to promote intestinal Ca2+ absorption. However, the molecules driving the paracellular Ca2+ absorption and its vitamin D dependency remain obscure. Because the tight junction proteins claudins are suggested to form paracellular channels for selective ions between neighboring cells, we hypothesized that specific intestinal claudins might facilitate paracellular Ca2+ transport and that expression of these claudins could be induced by 1α,25(OH)2D3. Herein, we show, by using RNA interference and overexpression strategies, that claudin-2 and claudin-12 contribute to Ca2+ absorption in intestinal epithelial cells. We also provide evidence showing that expression of claudins-2 and -12 is up-regulated in enterocytes in vitro and in vivo by 1α,25(OH)2D3 through the vitamin D receptor. These findings strongly suggest that claudin-2- and/or claudin-12-based tight junctions form paracellular Ca2+ channels in intestinal epithelia, and they highlight a novel mechanism behind vitamin D-dependent calcium homeostasis.

1 December 2017 in Developmental Cell
Verified
Journal Article
Closed access
SHSubhra P. Hui
Subhra P. Hui
DSDelicia Z. Sheng
Delicia Z. Sheng
Kotaro SugimotoKotaro Sugimoto
Kotaro Sugimoto
AGAlvaro Gonzalez-Rajal
Alvaro Gonzalez-Rajal
SNShinichi Nakagawa
Shinichi Nakagawa
KKazu Kikuchi
Kazu Kikuchi

10 August 2017 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
HSHongjun Shi
Hongjun Shi
AEAnnabelle Enriquez
Annabelle Enriquez
MRMelissa Rapadas
Melissa Rapadas
EMElla M.M.A. Martin
Ella M.M.A. Martin
RWRoni Wang
Roni Wang
SDSally Dunwoodie
Sally Dunwoodie
Congenital malformations can be manifested as combinations of phenotypes that co-occur more often than expected by chance. In many such cases, it has proved difficult to identify a genetic cause. We sought the genetic cause of cardiac, vertebral, and renal defects, among others, in unrelated patients. We used genomic sequencing to identify potentially pathogenic gene variants in families in which a person had multiple congenital malformations. We tested the function of the variant by using assays of in vitro enzyme activity and by quantifying metabolites in patient plasma. We engineered mouse models with similar variants using the CRISPR (clustered regularly interspaced short palindromic repeats)–Cas9 system. Variants were identified in two genes that encode enzymes of the kynurenine pathway, 3-hydroxyanthranilic acid 3,4-dioxygenase (HAAO) and kynureninase (KYNU). Three patients carried homozygous variants predicting loss-of-function changes in the HAAO or KYNU proteins (HAAO p.D162*, HAAO p.W186*, or KYNU p.V57Efs*21). Another patient carried heterozygous KYNU variants (p.Y156* and p.F349Kfs*4). The mutant enzymes had greatly reduced activity in vitro. Nicotinamide adenine dinucleotide (NAD) is synthesized de novo from tryptophan through the kynurenine pathway. The patients had reduced levels of circulating NAD. Defects similar to those in the patients developed in the embryos of Haao-null or Kynu-null mice owing to NAD deficiency. In null mice, the prevention of NAD deficiency during gestation averted defects. Disruption of NAD synthesis caused a deficiency of NAD and congenital malformations in humans and mice. Niacin supplementation during gestation prevented the malformations in mice. (Funded by the National Health and Medical Research Council of Australia and others.)

1 August 2006 in Journal of Histochemistry & Cytochemistry
Verified
Journal Article
Closed access
HFHiroki Fujita
Hiroki Fujita
HCHideki Chiba
Hideki Chiba
HYHiroshi Yokozaki
Hiroshi Yokozaki
NSNaoyuki Sakai
Naoyuki Sakai
Kotaro SugimotoKotaro Sugimoto
Kotaro Sugimoto
NSNorimasa Sawada
Norimasa Sawada
Among tight-junction proteins, claudins, which play a key role in paracellular transport across epithelia, claudins 1 to 5 are expressed in the intestine, and changes in their abundance and/or distribution are considered to contribute to various gastrointestinal diseases. We investigated, by reverse transcription-PCR, immunoblot, and immunofluorescence analyses, which other claudin species were expressed in the mouse intestine, and whether they showed unique expression profiles. Rabbit polyclonal antibodies against mouse claudin-8, claudin-12, and claudin-15 were generated, and their specificity was verified by immunoblotting using COS-7 cells transfected with individual claudin cDNAs. Claudin-7, −8, −12, −13, and −15 appeared to be expressed in the duodenum, jejunum, ileum, and/or colon with remarkable variations in the expression levels along the intestinal tract, and had distinct subcellular localization in the intestinal epithelium. In addition, claudin-13 and −15 exhibited gradients along the crypt-surface axis of the colon. By contrast, claudin-6, −9, −10, −11, −14, −16, −18, and −19 were not observed in the intestine. Our results indicate that five additional species of claudins have very complex expression patterns along and within the intestine, and that this may reflect differences in paracellular permeable properties, providing valuable resources for studying the significance of these claudins in gastrointestinal disorders. This manuscript contains online supplemental material available at http://www.jhc.org . Please visit this article online to view these materials.

9 April 2021 in Science
Verified
Journal Article
Closed access
PDF file
MOMasahito Ogawa
Masahito Ogawa
FGFan-Suo Geng
Fan-Suo Geng
DHDavid T. Humphreys
David T. Humphreys
EKEsther Kristianto
Esther Kristianto
DSDelicia Z. Sheng
Delicia Z. Sheng
KKazu Kikuchi
Kazu Kikuchi
Repairing the fish heart: Although humans show minimal regenerative capability, zebrafish can regenerate their hearts through a mechanism whereby heart muscle cells (cardiomyocytes) revert to a less mature state and then proliferate to replace the damaged tissue. Ogawa et al. show that Krüppel-like factor 1 (Klf1/Eklf), a transcription factor well known for its role in red blood cell development, is an essential factor for heart regeneration in zebrafish. Klf1 is specifically expressed in cardiomyocytes after injury, and its activation is sufficient to stimulate new cardiomyocyte production without injury. This potent effect is achieved through reprogramming of gene networks regulating cardiomyocyte differentiation and mitochondrial metabolism. Science , this issue p. 201

1 August 2017 in Developmental & Comparative Immunology
Verified
Journal Article
Closed access
Kotaro SugimotoKotaro Sugimoto
Kotaro Sugimoto
SHSubhra P. Hui
Subhra P. Hui
DSDelicia Z. Sheng
Delicia Z. Sheng
MNMaki Nakayama
Maki Nakayama
KKazu Kikuchi
Kazu Kikuchi